{"url_path":"/sec/ima/8-k/2026-06-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1835579/0001193125-26-274139-index.html","accession_number":"0001193125-26-274139","cik":"0001835579","ticker":"IMA","issuer_name":"ImageneBio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1835579/0001193125-26-274139-index.html","primary_entity_key":"0001835579","primary_entity_name":"ImageneBio, Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\n  \n\nDescription\n\n10.1\n  \n[ImageneBio, Inc. Amended and Restated 2025 Equity Incentive Plan.](d114862dex101.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nIMAGENEBIO, INC.\n\nDate: June 17, 2026\n \n\n \nBy:\n \n\n/s/ Kristin Yarema\n\n \n\n \n\n \nKristin Yarema, Ph.D.\n\n \n\n \n\n \nChief Executive Officer"}